[Proteinuria: many actors but one protagonist?].
Grosjean
Fabrizio
F
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D006595:Hexosamines / Q000096:biosynthesis; D006801:Humans; D007678:Kidney Glomerulus / Q000378:metabolism*; D007687:Kidney Tubules, Proximal / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D009701:Nucleoside-Diphosphate Kinase / Q000172:deficiency / Q000502:physiology; D050199:Podocytes / Q000378:metabolism; D011507:Proteinuria / Q000188:drug therapy / Q000209:etiology*; D012795:Sialoglycoproteins / Q000378:metabolism
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D006595:Hexosamines; D012795:Sialoglycoproteins; C001643:podocalyxin; C029260:uridine diphosphate kinase; D009701:Nucleoside-Diphosphate Kinase; C002022:N-acetylmannosamine